Results of a study examining Brentuximab Vedotin combined with chemotherapy for first line treatment of pediatric anaplastic large cell lymphoma.
Home / Resource Library / Brentuximab vedotin in combination with standard chemotherapy for pediatric patients with newly diagnosed, ALK+ ALCL